title: [Legal boundaries of negative and positive lists].
abstract: Positive lists comprise only a limited number of medicines destined for reimbursement by the health insurance companies. Intentions to publicize those lists at federal and provincial levels failed for constitutional reasons. Negative lists--on the other hand--as prepared by health insurance companies are admissible as long as they are--among other things--open for changes according to the scientific progress. Medicines being incorporated into a negative list can be prescribed but are not reimbursable.
authors.affiliation: Rechtsanwaltsbüro Schön, Nolte, Finkelnburg & Clemm, Berlin.
authors.forename: M
authors.initials: M
authors.lastname: Arndt
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D005858:Germany; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D009313:National Health Programs / Q000331:legislation & jurisprudence*; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence
vernacular_title: Rechtliche Grenzziehungen bei Negativ- und Positivlisten.